Patents Assigned to AZIENDE CHIM. RIUN. ANGEL. FRA. A.C.R.A.F. S.p.A.
  • 1-BENZYL-3-HYDROXYMETHYLINDAZOLE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1 AND CX3CR1
    Publication number: 20130012510
    Abstract: The present invention relates to novel 1-benzyl-3-hydroxymethylindazole derivatives according to formula (I) described in the claims, and to a pharmaceutical composition comprising them, together with a pharmaceutically acceptable vehicle. In addition, the present invention relates to the use of novel 1-benzyl-3-hydroxymethylindazole derivatives for the preparation of a pharmaceutical composition that is active in the treatment of diseases based on the expression of MCP-1 and CX3CR1, and to their use in a method for treating or preventing diseases based on the expression of MCP-1 and CX3CR1.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: AZIENDE CHIM. RIUN. ANGEL. FRA. A.C.R.A.F. S.p.A.
    Inventors: Angelo GUGLIELMOTTI, Guido FURLOTTI, Giorgina MANGANO, Nicola CAZZOLLA
  • PACKAGING MATERIAL FOR A PHARMACEUTICAL PRODUCT HAVING A COLOURED ELEMENT WHICH AT A PREDETERMINED TEMPERATURE DISCOLOURS PARTIALLY, REVEALING A MARKING, AND METHOD FOR PRODUCING THIS MATERIAL
    Publication number: 20110217487
    Abstract: It is disclosed a packaging material for a pharmaceutical product. The packaging material comprises a coloured element which at about 38° C. discolours partially, revealing a marking. The element is formed by a first portion forming the marking printed with conventional ink, and a second portion printed with thermochromic ink. The thermochromic ink is coloured below about 38° C. and becomes colourless when this temperature is reached or exceeded. The two portions are arranged so that the first portion is invisible below about 38° C., but becomes visible when this temperature is reached or exceeded.
    Type: Application
    Filed: November 13, 2009
    Publication date: September 8, 2011
    Applicant: AZIENDE CHIM. RIUN. ANGEL. FRA. A.C.R.A.F S.p.A.
    Inventor: Roberto Masciambruni
  • 1-BENZYL-3-HYDROXYMETHYLINDAZOLE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1 AND CX3CR1
    Publication number: 20100317618
    Abstract: The present invention relates to novel 1-benzyl-3-hydroxymethylindazole derivatives according to formula (I) described in the claims, and to a pharmaceutical composition comprising them, together with a pharmaceutically acceptable vehicle. In addition, the present invention relates to the use of novel 1-benzyl-3-hydroxymethylindazole derivatives for the preparation of a pharmaceutical composition that is active in the treatment of diseases based on the expression of MCP-1 and CX3CR1, and to their use in a method for treating or preventing diseases based on the expression of MCP-1 and CX3CR1.
    Type: Application
    Filed: March 6, 2009
    Publication date: December 16, 2010
    Applicant: AZIENDE CHIM. RIUN. ANGEL. FRA. A.C.R.A.F. S.p.A.
    Inventors: Angelo Guglielmotti, Guido Furlotti, Giorgina Mangano, Nicola Cazzolla
  • INDAZOLE HAVING ANALGESIC ACTIVITY
    Publication number: 20100094015
    Abstract: An intermediate of formula (II)
    Type: Application
    Filed: December 15, 2009
    Publication date: April 15, 2010
    Applicant: AZIENDE CHIM. RIUN. ANGEL. FRA. A.C.R.A.F. S.p.A.
    Inventors: Maria Alessandra Alisi, Nicola Cazzolla, Guido Furlotti, Angelo Guglielmotti, Lorenzo Polenzani